Search Results - "Codony, C."

Extended lower paratracheal lymph node resection during esophagectomy for cancer - safety and necessity by Mann, C, Berlth, F, Hadzijusufovic, E, Tagkalos, E, Uzun, E, Codony, C, Lang, H, Grimminger, P P

“…The ideal extent of lymphadenectomy (LAD) in esophageal oncological surgery is debated. There is no evidence for improved survival after standardized…”
Get full text

Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the detection of siRNA, miRNA and piRNA by northern blot by Pall, Gurman Singh, Codony-Servat, Carles, Byrne, Jane, Ritchie, Leigh, Hamilton, Andrew

“…The northern blot, or RNA gel blot, is a widely used method for the discovery, validation and expression analysis of small regulatory RNA such as small…”
Get full text

Extreme liver surgery as treatment of liver tumors involving the hepatocaval confluence by Codony, C., López-Ben, S., Albiol, M., Falgueras, L., Castro, E., Codina-Barreras, A., Casellas, M., Gil, J., Codina-Cazador, A., Figueras, J.

“…Objective Analyze the characteristics, surgical technique, morbidity and survival of patients treated with extreme liver surgery. Materials and methods We…”
Get full text

P-174 Outcomes in local gastric cancer resected without neoadjuvant therapy: A descriptive study by Buscarons, E. Bujons, Ferrer, C. Montañes, Marti, L. Llavata, Ortega, J. Sabaté, Bassols, C. Codony, Velasco, A. García, Pujadas de Palol, M., Hernández-Yagüe, X., Sanchez, R. Guardeño

Get full text

Post-transcriptional regulation of rat carnitine octanoyltransferase by Hegardt, F G, Bach, M, Asins, G, Caudevilla, C, Morillas, M, Codony, C, Serra, D

“…Carnitine octanoyltransferase (COT) produces three different transcripts in rat through cis- and trans-splicing reactions, which can lead to the synthesis of…”
Get more information

A Second-Step Splicing Activity Is Conserved from Yeast to Human by Cicarelli, R.M.B., Khaouja, A., Codony, C., Espuny, R., Eritja, R., Bach-Elias, M.

“…We describe a defective HeLa nuclear extract which is particularly deficient in step 2 of splicing reaction. With this extract we have studied the conservation…”
Get full text

Biomarker driven combinations for synthetic lethal approaches in KRAS mutant (KRASm) lung adenocarcinoma (LAC) by Lazzari, C., Verlicchi, A., Servat, C. Codony, Servat, J. Codony, Vila, M.A. Molina, Chaib, I., Serrano, J.L. Ramírez, Karachaliou, N., de Marinis, F., Rosell, R.

Get full text

Differential expression profile of lung squamous cell carcinoma (LSCC) and druggable targets to be combined with necitumumab (N) by Verlicchi, A., Lazzari, C., Servat, C. Codony, Vila, M.A. Molina, Servat, J. Codony, Chaib, I., Serrano, J.L. Ramírez, Karachaliou, N., Dazzi, C., Rosell, R.

Get full text

148INCAN WE DO BETTER WITH OUR CURRENT THERAPIES FOR NSCLC? THE SPANISH LUNG CANCER GROUP APPROACH by Rosell, R., Karachaliou, N., Molina, M.A., Codony, J., Ramirez, J.L., Chaib, I., Garcia-Roman, S., Morales-Espinosa, D., Estrada, R., Bertran, J., Codony, C., Gimenez-Capitan, A., Gonzalez-Cao, M., Sureda, B. Massuti, Vergnenegre, A., Moran, T., Carcereny, E., Teixido, C., Villanueva, A., Sanchez-Ronco, M.

“…Abstract Aim: In the SLCG large-scale screening, 16.6% of EGFR mutations were found, median PFS and OS for pts receiving erlotinib was 14 mos and 27 mos,…”
Get full text

Can we Do Better with Our Current Therapies for Nsclc? the Spanish Lung Cancer Group Approach by Rosell, R., Karachaliou, N., Molina, M.A., Codony, J., Ramirez, J.L., Chaib, I., Garcia-Roman, S., Morales-Espinosa, D., Estrada, R., Bertran, J., Codony, C., Gimenez-Capitan, A., Gonzalez-Cao, M., Sureda, B. Massuti, Vergnenegre, A., Moran, T., Carcereny, E., Teixido, C., Villanueva, A., Sanchez-Ronco, M.

Get full text

Natural Trans-Splicing in Carnitine Octanoyltransferase Pre-MRNAs in Rat Liver by Caudevilla, Concha, Serra, Dolors, Miliar, Angel, Codony, Carles, Asins, Guillermina, Bach, Montserrat, Hegardt, Fausto G.

“…Carnitine octanoyltransferase (COT) transports medium-chain fatty acids through the peroxisome. During isolation of a COT clone from a rat liver library, a…”
Get full text

1967PTriple MET/SRC/PIM inhibition in MET addicted tumors by Attili, I, Bonanno, L, Bracht, J P, Berenguer, J, Codony-Servat, C, Codony-Servat, J, Ito, M, Conte, P F, Cui, J J, Karachaliou, N, Rosell, R

“…Abstract Background MET addicted tumors are known to show very short response to single MET inhibition. In MET addicted cells, MET inhibition leads to…”
Get full text

1967P - Triple MET/SRC/PIM inhibition in MET addicted tumors by Attili, I., Bonanno, L., Bracht, J.P., Berenguer, J., Codony-Servat, C., Codony-Servat, J., Ito, M., Conte, P.F., Cui, J.J., Karachaliou, N., Rosell, R.

“…MET addicted tumors are known to show very short response to single MET inhibition. In MET addicted cells, MET inhibition leads to activation of proviral…”
Get full text

Triple MET/SRC/PIM inhibition in MET addicted tumors by Attili, I., Bonanno, L., Bracht, J.P., Berenguer, J., Codony-Servat, C., Codony-Servat, J., Ito, M., Conte, P.F., Cui, J.J., Karachaliou, N., Rosell, R.

Get full text

Hsp90 inhibitors enhance the antitumoral effect of osimertinib and overcome osimertinib resistance in non-small cell cell lung cancer cell models by Codony-Servat, J., Codony-Servat, C., Viteri, S., Ito, M., Chaib, I., Bracht, J., Molina-Vila, M.A., Karachaliou, N., Rosell, R.

Get full text

35P - Hsp90 inhibitors enhance the antitumoral effect of osimertinib and overcome osimertinib resistance in non-small cell cell lung cancer cell models by Codony-Servat, J., Codony-Servat, C., Viteri, S., Ito, M., Chaib, I., Bracht, J., Molina-Vila, M.A., Karachaliou, N., Rosell, R.

“…The epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) osimertinib improves therapy for non-small cell lung cancer (NSCLC) patients who…”
Get full text

35PHsp90 inhibitors enhance the antitumoral effect of osimertinib and overcome osimertinib resistance in non-small cell cell lung cancer cell models by Codony-Servat, J, Codony-Servat, C, Viteri, S, Ito, M, Chaib, I, Bracht, J, Molina-Vila, M A, Karachaliou, N, Rosell, R

“…Abstract Background The epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) osimertinib improves therapy for non-small cell lung cancer…”
Get full text

Localization of an exonic splicing enhancer responsible for mammalian natural trans-splicing by Caudevilla, C, Codony, C, Serra, D, Plasencia, G, Román, R, Graessmann, A, Asins, G, Bach-Elias, M, Hegardt, F G

“…Carnitine octanoyltransferase (COT) produces three different transcripts in rat through cis- and trans-splicing reactions, which may lead to the synthesis of…”
Get full text

Modulation in vitro of H-ras oncogene expression by trans-splicing by CODONY, Carles, GUIL, Sonia, CAUDEVILLA, Concha, SERRA, Dolors, ASINS, Guillermina, GRAESSMANN, Adolf, HEGARDT, Fausto G, BACH-ELIAS, Montse

“…In man, activated N-, K- and H-ras oncogenes have been found in around 30% of the solid tumours tested. An exon known as IDX, which has been described…”
Get full text

Processing of carnitine octanoyltransferase pre-mRNAs by cis and trans-splicing by Caudevilla, C, Serra, D, Miliar, A, Codony, C, Asins, G, Bach, M, Hegardt, F G

“…Trans-splicing is a mechanism by which two pre-mRNAs are processed to produce a mature transcript that contains exons from both precursors. This process has…”
Get more information